510(k) K080561
K080561 is an FDA 510(k) premarket notification submitted by bioMerieux, Inc. for the device "VIDAS CA 125 II ASSAY". The FDA issued a decision of Substantially Equivalent on Apr 10, 2009. The device falls under product code LTK (Test, Epithelial Ovarian Tumor-Associated Antigen (Ca125)), a Class II device regulated under 21 CFR 866.6010. bioMerieux, Inc. has 272 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Apr 10, 2009
- Date Received
- Feb 28, 2008
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Test, Epithelial Ovarian Tumor-Associated Antigen (Ca125)
- Device Class
- Class II
- Regulation Number
- 866.6010
- Review Panel
- IM
- Submission Type
- 510(k)
Need the full FDA record for bioMerieux, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.